Androgenetic Alopecia

Androgenetic alopecia (AGA) is a prevalent condition affecting men worldwide, significantly impacting self-image and quality of life. The incidence of AGA increases with age, affecting 30% of men by age 25 and 53% by ages 40-49, with higher severity in Caucasian men. Despite its high prevalence, AGA is often trivialized, yet it is linked to psychological issues like anxiety and depression. While some studies suggest associations with cardiovascular diseases and prostate conditions, only the link between prostate cancer and vertex baldness is confirmed. Current treatments include antiandrogens, minoxidil, platelet-rich plasma, and hair transplants, but a complete reversal remains elusive. The document provides an update on the etiology, pathogenesis, and treatment of AGA, highlighting ongoing research and the significant financial investment in addressing this condition.